Ibandronate Sodium 150MG Tablets

Contract SPE2D2-21-D-0128 is a firm fixed price requirements contract awarded by the Defense Logistics Agency DLA Troop Support to Golden State Medical Supply, Inc. for the procurement of Ibandronate Sodium 150MG tablets in 3 count packs. The contract was awarded under full and open competition and is set aside for 8(a) participants. The total estimated value of the award is 4,547,341.50 dollars, covering a five year period consisting of a base year and three option years. Each year has an estimated quantity of 50,695 packs at a unit price of 17.94 dollars. The product is manufactured by Apotex in Canada and distributed through Golden State Medical Supply in Camarillo, California. The contract has been managed through several modifications, including the exercise of Option 1, Option 2, and Option 3, with the final option extending the period of performance through May 23, 2025. Additionally, modifications were issued to update the National Drug Code for the supplied medication. Delivery is conducted FOB Destination, meaning the contractor retains risk and cost until the supplies reach their destination. Compliance is governed by various FAR and DFARS clauses, including requirements for electronic invoicing via Wide Area Workflow, safeguarding covered defense information, and adherence to small business subcontracting plans.